[Challenges in the treatment of opioid dependence].

IF 0.9 4区 医学 Q4 CLINICAL NEUROLOGY Nervenarzt Pub Date : 2024-09-01 Epub Date: 2024-07-15 DOI:10.1007/s00115-024-01691-9
Andreas Heinz, Stefan Gutwinski, Michael Krausz, Gernot Ernst, Marc Vogel, Norbert Scherbaum
{"title":"[Challenges in the treatment of opioid dependence].","authors":"Andreas Heinz, Stefan Gutwinski, Michael Krausz, Gernot Ernst, Marc Vogel, Norbert Scherbaum","doi":"10.1007/s00115-024-01691-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The number of persons using opioids has increased worldwide in the last decade, particularly the use of opioid analgesics in North America and Africa. In Germany, the prevalence of heroin addiction has remained relatively stable.</p><p><strong>Method: </strong>Narrative review of the literature.</p><p><strong>Results: </strong>Opioid-assisted maintenance treatment (OMT) with the established substances methadone, levomethadone, slow-release morphine and buprenorphine is recommended as the first-line treatment for heroin dependence. The OMT reduces the use of heroin, mortality and individual suffering and improves the quality of life and physical health. A diamorphine and heroine-assisted treatment is an option for people who do not benefit from conventional OMT. An alternative to the use of diamorphine could be treatment with hydromorphone hydrochloride. The regulations on carrying out maintenance treatment in the Controlled Substances Prescription Act and the guidelines of the Federal Medical Association in Germany have been loosened based on the experiences of the COVID-19 pandemic, for example with respect to take-home prescriptions. There is an ongoing intensive discussion on how to deal with the decreasing number of outpatient clinics offering OMT.</p><p><strong>Conclusion: </strong>The first-line treatment for opioid addiction is opioid-assisted substitution treatment, including diamorphine and heroin-assisted treatment. Long-acting depot medications and implants still play a subordinate role.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"811-817"},"PeriodicalIF":0.9000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nervenarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00115-024-01691-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The number of persons using opioids has increased worldwide in the last decade, particularly the use of opioid analgesics in North America and Africa. In Germany, the prevalence of heroin addiction has remained relatively stable.

Method: Narrative review of the literature.

Results: Opioid-assisted maintenance treatment (OMT) with the established substances methadone, levomethadone, slow-release morphine and buprenorphine is recommended as the first-line treatment for heroin dependence. The OMT reduces the use of heroin, mortality and individual suffering and improves the quality of life and physical health. A diamorphine and heroine-assisted treatment is an option for people who do not benefit from conventional OMT. An alternative to the use of diamorphine could be treatment with hydromorphone hydrochloride. The regulations on carrying out maintenance treatment in the Controlled Substances Prescription Act and the guidelines of the Federal Medical Association in Germany have been loosened based on the experiences of the COVID-19 pandemic, for example with respect to take-home prescriptions. There is an ongoing intensive discussion on how to deal with the decreasing number of outpatient clinics offering OMT.

Conclusion: The first-line treatment for opioid addiction is opioid-assisted substitution treatment, including diamorphine and heroin-assisted treatment. Long-acting depot medications and implants still play a subordinate role.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[阿片类药物依赖治疗的挑战]。
背景:在过去十年中,全球使用阿片类药物的人数有所增加,尤其是在北美和非洲使用阿片类镇痛药的人数。在德国,海洛因成瘾的流行率保持相对稳定:方法:对文献进行叙述性回顾:结果:阿片类药物辅助维持治疗(OMT)与美沙酮、左美沙酮、缓释吗啡和丁丙诺啡等成熟药物被推荐作为治疗海洛因依赖的一线疗法。OMT 可以减少海洛因的使用,降低死亡率,减轻个人痛苦,提高生活质量和身体健康水平。对于那些无法从传统 OMT 中获益的人,可以选择二羟吗啡和海洛因辅助治疗。除了使用二羟吗啡,还可以使用盐酸氢吗啡酮进行治疗。根据 COVID-19 大流行的经验,德国的《受控物质处方法》和联邦医学协会的指导方针中关于进行维持治疗的规定已经有所松动,例如在带回家的处方方面。关于如何应对提供 OMT 的门诊诊所数量不断减少的问题,目前正在进行深入讨论:阿片类药物成瘾的一线治疗是阿片类药物辅助替代治疗,包括二吗啡和海洛因辅助治疗。长效去势药物和植入药物仍处于从属地位。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nervenarzt
Nervenarzt 医学-精神病学
CiteScore
2.50
自引率
18.20%
发文量
169
审稿时长
4-8 weeks
期刊介绍: Der Nervenarzt is an internationally recognized journal addressing neurologists and psychiatrists working in clinical or practical environments. Essential findings and current information from neurology, psychiatry as well as neuropathology, neurosurgery up to psychotherapy are presented. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of neurology and psychiatry. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
期刊最新文献
[Involvement of representatives of patients and relatives in guideline processes : S3 guidelines on psychosocial therapies for severe mental illnesses breaks new ground]. [Cognitive impairments associated with schizophrenic psychoses : Diagnostics, course and therapy]. [Neurorehabilitation]. [Parenthood and mental diseases]. [Goodbye-Valued members of the German Society for Neurology].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1